Asset Details

MbrlCatalogueTitleDetail

Do you wish to reserve the book?

Dual Antithrombotic Therapy with Dabigatran after PCI in Atrial Fibrillation

by Cannon, Christopher P , Bhatt, Deepak L , Oldgren, Jonas , Lip, Gregory Y.H , Harper, Ruth , Zeymer, Uwe , Manassie, Jenny , ten Berg, Jurrien M , Maeng, Michael , Gropper, Savion , Steg, P. Gabriel , Kimura, Takeshi , Ellis, Stephen G , Nordaby, Matias , Kleine, Eva , Merkely, Bela , Hohnloser, Stefan H , Januzzi, James L

in Adenosine - adverse effects / Adenosine - analogs & derivatives / Adenosine - therapeutic use / Aged / Anticoagulants / Anticoagulants - adverse effects / Anticoagulants - therapeutic use / Antiplatelet therapy / Aspirin / Aspirin - therapeutic use / Atrial Fibrillation - drug therapy / Atrial Fibrillation - therapy / Bleeding / Cardiac arrhythmia / Cardiology / Cerebral infarction / Clopidogrel / Dabigatran - adverse effects / Dabigatran - therapeutic use / Drug dosages / Drug therapy / Drug Therapy, Combination - adverse effects / Embolism / Embolisms / Female / Fibrillation / Geriatrics / Hemorrhage - chemically induced / Hemorrhage - epidemiology / Humans / Incidence / Male / Middle Aged / Myocardial infarction / Percutaneous Coronary Intervention / Platelet Aggregation Inhibitors - therapeutic use / Preventive medicine / Purinergic P2Y Receptor Antagonists - adverse effects / Purinergic P2Y Receptor Antagonists - therapeutic use / Risk / Stroke / Thromboembolism / Thrombosis / Ticagrelor / Ticlopidine - analogs & derivatives / Ticlopidine - therapeutic use / Warfarin / Warfarin - adverse effects / Warfarin - therapeutic use

2017

Yes Please

Hey, we have placed the reservation for you!

By the way, why not check out events that you can attend while you pick your title.

Oops! Something went wrong.

Looks like we were not able to place the reservation. Kindly try again later.

Are you sure you want to remove the book from the shelf?

Dual Antithrombotic Therapy with Dabigatran after PCI in Atrial Fibrillation

2017

Confirm

Do you wish to request the book?

Dual Antithrombotic Therapy with Dabigatran after PCI in Atrial Fibrillation

2017

Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy

How would you like to get it?

Submit

We have requested the book for you!

Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.

Oops! Something went wrong.

Looks like we were not able to place your request. Kindly try again later.

Journal Article

Dual Antithrombotic Therapy with Dabigatran after PCI in Atrial Fibrillation

Cannon, Christopher P,

Bhatt, Deepak L,

Oldgren, Jonas,

Lip, Gregory Y.H,

Harper, Ruth,

Zeymer, Uwe,

Manassie, Jenny,

ten Berg, Jurrien M,

Maeng, Michael,

Gropper, Savion,

Steg, P. Gabriel,

Kimura, Takeshi,

Ellis, Stephen G,

Nordaby, Matias,

Kleine, Eva,

Merkely, Bela,

Hohnloser, Stefan H,

Januzzi, James L

2017

Overview

In this trial, dabigatran plus a P2Y 12 inhibitor was compared with warfarin plus a P2Y 12 inhibitor and aspirin after PCI in patients with atrial fibrillation. The risk of bleeding was lower with dabigatran therapy; prevention of thromboembolic events was similar with the two strategies.

Share this book

Add to My Shelf

Publisher

Massachusetts Medical Society

Subject

Adenosine - adverse effects

/ Adenosine - analogs & derivatives

/ Adenosine - therapeutic use

/ Aged

/ Anticoagulants

/ Anticoagulants - adverse effects

/ Anticoagulants - therapeutic use